In this time of inflammation around the speedup of diabetes technology, it's not all nearly the Artificial Pancreas. Flatbottom the insulin indite injection devices that many of us habituate are acquiring smarter, with built-in Bluetooth allowing users to track doses and trends and share that data for a much complete direction picture.

This International Relations and Security Network't a new phenom, as we've seen these "smart pens" in the works for many years — from Lilly's HumaPen Memoir pen individual years past, the Timesulin pen detonator, so the Ring pen from Novo Nordisk a couple years ago that tracks ancient doses surgery even the Bee pen detonator most recently.

Those are four different approaches to what English hawthorn be best viewed as "the initiatory generation of sharp pens."

And in real time, we're entering the next coevals with ii new, even more sophisticated connected pen devices coming out: the InPen from Companion Medical in San Diego, which received FDA approval in late July; and the Esysta smart pen from Emperra Digital Diabetes Tending in Germany, which was really launched in early August outside the U.S. and dubs therefore dubs itself "the world's first" insulin pen allowing for automatic data transfer via Bluetooth.

Atomic number 3 a refresher, in May Company Medical according that it adorned $3.2 billion from investors, including Eli Lilly. Here's a shot of the InPen's features we introductory reported connected in July 2015:

  • Contains computer chip applied science built suited into the base, including Bluetooth LE wireless capability
  • Is refillable using either Lilly or Novo insulin cartridges (the only two types of insulin getable in cartridges present in the U.S.)
  • Includes a temperature sensor built into the pen that sets off an app alarm if the pen's temp dips below freezing or to a higher place body temperature, ensuring that your insulin is intact
  • Collects users' data and transmits IT to an app that contains a dose calculator, and also calculates real-metre insulin on board (IOB)
  • Smartphone app also allows users to set up reminders for repast and snack times, and if you haven't treated aside the end of the set time window, the app will alarm
  • Allows unaccessible monitoring – users can set the app to automatically text message their dosing info to adequate to 5 people. This can include not only every insulin dose, but likewise BG and carb values (if entered manually) — totally compiled into a widowed text message

Happening July 27, the Food and Drug Administration cleared the InPen for ages 12 and older. Companion Medical's co-founder and CEO Sean Apotheosis says the San Diego company plans to launch this smart pen sometime in 2017, without giving a more specific date.

Canonize tells us the write comes in deuce models, designed for the Novo and Lilly insulin cartridges. Spell the cardinal versions look and occasion the synoptical, aside design you can't confuse the two because each cartridge is specific to that pen and buns't be used in the other.

As to pricing, Saint isn't set to talk inside information on that simply says they "plan to pursue pharmacy reimbursement" sol that a patient will only have to pay a "tenable" co-pay.

We also asked Saint about the recent news of the Emperra-organized smart pen hitting the market internationally. He says helium's grateful other companies are developing these insulin delivery devices. Clearly, he sees the InPen design as better for patients, as it's smaller and simpler solution in the gumption information technology doesn't need a disposal adapter like Emperra's playpen. He reiterates that competition is good, while noting that spell InPen may not be kickoff to market whole, it is the first FDA-approved smart playpen set to launch before long here in the U.S.

"Our plans aflare forward are laser-centralised along commercialization," he told us following the Food and Drug Administration commendation. "We do have several additional products in development, but are non ready to verbalize about those. It is a precise provocative time with a good deal of new potentiality available operating room coming soon."

You may have seen the press let go of ostentation approximately this one. The new saucy playpen is dubbed the ESYSTA, a name that plays off the lyric "electronic," "system," and "leisurely to manipulation." It is the world's best of its kind, per the digital tech health company in Germany. We contiguous with Dr. Janko Schildt, Emperra's chief medic and managing director, to larn more.

This pen and its various components are Common Era-marked in Europe, and Schildt says they has filed with the FDA and expects approval toward the end of 2016 — so it may very fountainhead be neck and neck with the InPen.

You can see the German company's web site translated into English here, oblation into on the business and all of its products including the insulin pen, moveable wellness app, an online platform, and a glucose meter in developing.

ESYSTA's features admit:

Share on Pinterest

  • Holds as much every bit 60 units of insulin
  • Has design dimensions of 180 millimetre long-wooled, 23 mm intoxicated, 25 mm recondite, and 65 grams weight
  • Works with all tercet insulins on the commercialize — from Lilly, Novo and Sanofi. You simply attach one of three adapters for the insulin type, with no need to change the pen body
  • Blind window shows last insulin dose amount and how durable since you took that injection
  • Has a countdown to when your next shot is needed
  • Stores 1,000 data sets
  • Uses regular batteries that can cost replaced
  • You can enter glucose results and carb info to calculate insulin-dosing information
  • Sends insulin pen data to a cloud-based ESYSTA portal, which you can view online and set to share information with others ilk caregivers or your health care team. The data tush besides be conveyed to a raiseable app comparable with with both Android Oregon iOS devices

The compose doesn't presently communicate with other diabetes tracking apps, merely the company says they are collaborating with many German-based telecommunication providers to develop a platform for interoperability. All of the data can currently be entered manually into the app.

Share on Pinterest

Share connected Pinterest

Emperra is likewise exploring policy reimbursement, using clinical study data on down A1Cs from a pilot project at the University of Dresden that enclosed 200+ PWDs (multitude with diabetes) for more than a year. They've already secured full reimbursement for patients in Germany, and are now focused on contracting with additional telemedicine and coaching armed service providers to make this a more than comprehensive glide path for the U.S. market.

American Samoa to competitive advantage, Emperra says its ESYSTA is the only Bluetooth-enabled pen available in the world that fits all three insulin companies' pens.

Dr. Schildt says the company is also developing a new glucose metre that wish be competent to communicate with its insulin pens, and is working with Novo Biomedical in the US and ALPS Electric in Japan/Ireland/Germany to bring that to market.

Information technology's groovy see advanced technology being accustomed enhance all sorts of tools — so even patients who may never wear an Unlifelike Pancreas can profit from the power of information sharing.

These are exciting developments, and we look forward to eventually getting our hands on these two smart pens to test drive and share with our D-Community.